| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in developing ACE2 derivatives against SARS-CoV-2
|
Zhang, Haoran
|
|
|
|
5 |
p. e369-e378
|
artikel
|
| 2 |
Airborne transmission of MPXV and its aerosol dynamics under different viral load conditions
|
Lee, Byung Uk
|
|
|
|
5 |
p. e288-e289
|
artikel
|
| 3 |
A locally sustainable approach to COVID-19 testing in Africa
|
Songok, Elijah
|
|
|
|
5 |
p. e197
|
artikel
|
| 4 |
AMR in bacteria from humans, animals, and food in Europe
|
Bagcchi, Sanjeet
|
|
|
|
5 |
p. e299
|
artikel
|
| 5 |
Anthroponotic risk of SARS-CoV-2, precautionary mitigation, and outbreak management
|
Edwards, Sarah J L
|
|
|
|
5 |
p. e187-e188
|
artikel
|
| 6 |
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1
|
Mykytyn, Anna Z
|
|
|
|
5 |
p. e294-e295
|
artikel
|
| 7 |
Antimicrobial resistance: plus ça change
|
The Lancet Microbe,
|
|
|
|
5 |
p. e168
|
artikel
|
| 8 |
Appropriate antimicrobial use during the COVID-19 pandemic: not cause for complacency
|
Spernovasilis, Nikolaos
|
|
|
|
5 |
p. e293
|
artikel
|
| 9 |
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
|
Antonelli, Guido
|
|
|
|
5 |
p. e178
|
artikel
|
| 10 |
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
|
Sonnenkalb, Lindsay
|
|
|
|
5 |
p. e358-e368
|
artikel
|
| 11 |
Chikungunya in Brazil … and beyond?
|
The Lancet Microbe,
|
|
|
|
5 |
p. e284
|
artikel
|
| 12 |
Convalescent plasma from people vaccinated after COVID-19 infection
|
Jabal, Kamal Abu
|
|
|
|
5 |
p. e171-e172
|
artikel
|
| 13 |
Correction to Lancet Microbe 2022; 3: e173–83
|
|
|
|
|
5 |
p. e333
|
artikel
|
| 14 |
Correction to Lancet Microbe 2021; published online March 23. https://doi.org/10.1016/S2666-5247(21)00025-2
|
|
|
|
|
5 |
p. e179
|
artikel
|
| 15 |
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
|
Regev-Yochay, Gili
|
|
|
|
5 |
p. e309-e318
|
artikel
|
| 16 |
Coupling field and laboratory studies of immunity and infection in zoonotic hosts
|
Becker, Daniel J
|
|
|
|
5 |
p. e285-e287
|
artikel
|
| 17 |
COVID-19 and fungal infection: the need for a strategic approach
|
White, P Lewis
|
|
|
|
5 |
p. e196
|
artikel
|
| 18 |
Defining genomic epidemiology thresholds for common-source bacterial outbreaks: a modelling study
|
Duval, Audrey
|
|
|
|
5 |
p. e349-e357
|
artikel
|
| 19 |
El Salvador's malaria elimination success story
|
Balakrishnan, Vijay Shankar
|
|
|
|
5 |
p. e181
|
artikel
|
| 20 |
England's NIHP: self-sabotage ahead of bumpy months?
|
The Lancet Microbe,
|
|
|
|
5 |
p. e184
|
artikel
|
| 21 |
Extending political will into action in African LMICs: abating global antimicrobial resistance
|
Aruhomukama, Dickson
|
|
|
|
5 |
p. e327-e328
|
artikel
|
| 22 |
Frequency of transmission, asymptomatic shedding, and airborne spread of Streptococcus pyogenes in schoolchildren exposed to scarlet fever: a prospective, longitudinal, multicohort, molecular epidemiological, contact-tracing study in England, UK
|
Cordery, Rebecca
|
|
|
|
5 |
p. e366-e375
|
artikel
|
| 23 |
Histoplasmosis acquired in Alberta, Canada: an epidemiological and genomic study
|
Dingle, Tanis C
|
|
|
|
5 |
p. e191-e197
|
artikel
|
| 24 |
Ignoring SARS-CoV-2 testing performance during COVID-19
|
Buchta, Christoph
|
|
|
|
5 |
p. e296
|
artikel
|
| 25 |
Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study
|
Liu, Yan-Ning
|
|
|
|
5 |
p. e330-e339
|
artikel
|
| 26 |
In preparation for a COVID-19-influenza double epidemic
|
Balakrishnan, Vijay Shankar
|
|
|
|
5 |
p. e199
|
artikel
|
| 27 |
Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics
|
Schroeder, Simon
|
|
|
|
5 |
p. e210-e218
|
artikel
|
| 28 |
Learning from COVID-19 to reimagine tuberculosis diagnosis
|
Ruhwald, Morten
|
|
|
|
5 |
p. e169-e170
|
artikel
|
| 29 |
Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study
|
Chappell, Catherine A
|
|
|
|
5 |
p. e200-e208
|
artikel
|
| 30 |
Loci for prediction of penicillin and tetracycline susceptibility in Neisseria gonorrhoeae: a genome-wide association study
|
Mortimer, Tatum D
|
|
|
|
5 |
p. e376-e381
|
artikel
|
| 31 |
Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study
|
Massanella, Marta
|
|
|
|
5 |
p. e198-e209
|
artikel
|
| 32 |
Microbiome therapy for recurrent Clostridioides difficile
|
Gilbert, Judith A
|
|
|
|
5 |
p. e334
|
artikel
|
| 33 |
Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study
|
Ehrlich, Hanna Y
|
|
|
|
5 |
p. e209-e217
|
artikel
|
| 34 |
Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
|
Li, Pengfei
|
|
|
|
5 |
p. e325-e326
|
artikel
|
| 35 |
Nirsevimab: a promising therapy for RSV
|
Venkatesan, Priya
|
|
|
|
5 |
p. e335
|
artikel
|
| 36 |
No end in sight for the Brazilian COVID-19 crisis
|
Burki, Talha
|
|
|
|
5 |
p. e180
|
artikel
|
| 37 |
No time to lower the guard on AMR
|
Devi, Sharmila
|
|
|
|
5 |
p. e198
|
artikel
|
| 38 |
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial
|
Calvert, Anna
|
|
|
|
5 |
p. e300-e308
|
artikel
|
| 39 |
Pan-resistant Candida auris: New York subcluster susceptible to antifungal combinations
|
O'Brien, Brittany
|
|
|
|
5 |
p. e193-e194
|
artikel
|
| 40 |
Pathogenicity of mcr-1-positive Escherichia coli from human infections
|
Shen, Cong
|
|
|
|
5 |
p. e195
|
artikel
|
| 41 |
Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks
|
Kennedy-Shaffer, Lee
|
|
|
|
5 |
p. e219-e224
|
artikel
|
| 42 |
Persistent viral shedding after acute Lassa fever: thorough evidence arouses more noteworthy concerns
|
Ye, Wei
|
|
|
|
5 |
p. e329
|
artikel
|
| 43 |
Phenotypic instability of Mycobacterium tuberculosis strains harbouring clinically prevalent drug-resistant mutations
|
Chen, Yiwang
|
|
|
|
5 |
p. e292
|
artikel
|
| 44 |
Pneumonia surveillance with culture-independent metatranscriptomics in HIV-positive adults in Uganda: a cross-sectional study
|
Spottiswoode, Natasha
|
|
|
|
5 |
p. e357-e365
|
artikel
|
| 45 |
Post-recovery enhancement of anti-variant neutralisation after severe COVID-19
|
Lu, Yingying
|
|
|
|
5 |
p. e330-e331
|
artikel
|
| 46 |
Protecting intubated patients from the threat of antimicrobial resistant infections with monoclonal antibodies
|
Baker, Stephen
|
|
|
|
5 |
p. e191-e192
|
artikel
|
| 47 |
Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
|
Rhee, Soo-Yon
|
|
|
|
5 |
p. e392-e398
|
artikel
|
| 48 |
Repurposing bacteria to fight disease
|
Venkatesan, Priya
|
|
|
|
5 |
p. e298
|
artikel
|
| 49 |
Role of high-risk antibiotic use in incidence of health-care-associated Clostridioides difficile infection in Quebec, Canada: a population-level ecological study
|
Fortin, Elise
|
|
|
|
5 |
p. e182-e190
|
artikel
|
| 50 |
SARS-CoV-2: eye protection might be the missing key
|
Coroneo, Minas Theodore
|
|
|
|
5 |
p. e173-e174
|
artikel
|
| 51 |
SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study
|
Schlottau, Kore
|
|
|
|
5 |
p. e218-e225
|
artikel
|
| 52 |
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
|
Guo, Li
|
|
|
|
5 |
p. e348-e356
|
artikel
|
| 53 |
Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach
|
Cantillon, Daire
|
|
|
|
5 |
p. e382-e391
|
artikel
|
| 54 |
Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
|
Stone, Will
|
|
|
|
5 |
p. e336-e347
|
artikel
|
| 55 |
Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study
|
de Souza, William M
|
|
|
|
5 |
p. e319-e329
|
artikel
|
| 56 |
Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern
|
Mashe, Tapfumanei
|
|
|
|
5 |
p. e177
|
artikel
|
| 57 |
Survivability of H5N8 mixed wild bird droppings in different conditions
|
Zhang, Jiahao
|
|
|
|
5 |
p. e332
|
artikel
|
| 58 |
Tafenoquine for the prevention of Plasmodium vivax malaria relapse
|
Watson, James A
|
|
|
|
5 |
p. e175-e176
|
artikel
|
| 59 |
The challenges of informative wastewater sampling for SARS-CoV-2 must be met: lessons from polio eradication
|
O'Reilly, Kathleen M
|
|
|
|
5 |
p. e189-e190
|
artikel
|
| 60 |
The emerging antimicrobial resistance crisis during the COVID-19 surge in China
|
Wang, Zhicheng
|
|
|
|
5 |
p. e290-e291
|
artikel
|
| 61 |
The Lancet Microbe at 2: what is past is prologue
|
The Lancet Microbe,
|
|
|
|
5 |
p. e324
|
artikel
|
| 62 |
Towards pandemic preparedness beyond COVID-19
|
Naguib, Mahmoud M
|
|
|
|
5 |
p. e185-e186
|
artikel
|
| 63 |
Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study
|
Boehm, Alexandria B
|
|
|
|
5 |
p. e340-e348
|
artikel
|
| 64 |
Wastewater pathogen surveillance based on One Health approach
|
Xiao, Kangpeng
|
|
|
|
5 |
p. e297
|
artikel
|
Tijdschrift beschrijving